Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SLS

SELLAS Life Sciences Group Inc

May 22 • 04:00PM ET

7.78

+0.22 2.91 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: XNCR RCUS FATE KURA ADCT

| Held by: XBI IWM VTI IWO VXF VFMO VTWO IWC PTH DWAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.23	Insider Own	1.27%	Shs Outstand	186.03M	Perf Week	9.89%
Market Cap	1.45B	Forward P/E	-	EPS next Y	-0.15	Insider Trans	0.00%	Shs Float	185.21M	Perf Month	67.67%
Enterprise Value	1.34B	PEG	-	EPS next Q	-0.05	Inst Own	32.66%	Short Float	30.86%	Perf Quarter	72.89%
Income	-29.46M	P/S	-	EPS this Y	16.00%	Inst Trans	11.18%	Short Ratio	7.63	Perf Half Y	411.84%
Sales	0.00M	P/B	13.13	EPS next Y	28.57%	ROA	-39.50%	Short Interest	57.15M	Perf YTD	106.37%
Book/sh	0.59	P/C	13.50	EPS next 5Y	50.68%	ROE	-43.58%	52W High	9.10 -14.50%	Perf Year	342.05%
Cash/sh	0.58	P/FCF	-	EPS past 3/5Y	51.28% 34.92%	ROIC	-27.35%	52W Low	1.39 459.71%	Perf 3Y	352.33%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	14.04% 9.22%	Perf 5Y	-20.21%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	41.60%	Oper. Margin	-	ATR (14)	0.70	Perf 10Y	-99.98%
Dividend Ex-Date	Mar 24, 2011	Quick Ratio	17.22	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	64.76	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	17.22	EPS Q/Q	26.44%	SMA20	29.69%	Beta	2.34	Target Price	10.00
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	47.01%	Rel Volume	1.42	Prev Close	7.56
Employees	13	LT Debt/Eq	0.00	Earnings	May 12 AMC	SMA200	134.41%	Avg Volume	7.49M	Price	7.78
IPO	Mar 12, 2008	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.67% -	Trades		Volume	10,642,175	Change	2.91%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)